Copyright © 1990 by the European Society of Cardiology.
© 1990 The European Society of Cardiology
Enzyme release after elective cardioversion
*Department of Anaesthesiology, Dunderyds Hospital and the Division of Cardiology Stockholm, Sweden
Department of Medicine, Karolinska Hospital, Karolinska Institute Stockholm, Sweden
Received 2 May 1989; revised 11 December 1989; .
Requests for reprints. J Jakobsson, Department of Anaesthesiology and Intensive Care, Danderyd, Hospital, S-182 88 Danderyd, Sweden.
Abstract
Electrical cardioversion is reported to be associated with some degree of skeletal muscle and myocardial damage. In the present study, total creatine kinase (S-CK) and the activity of the subunit S-CK-B activity have been measured in serum after elective cardioversion in 30 patients. The enzyme activity peaked during a 28-h observation period. S-CK increased from 72±6 (mean±SEM) U l–1 (1.2± 0.1 ukat l–1) to a maximal value of 990 ± 258 u l–1 (16.5 ± 4.3 ukat l–1) and S-CK-B (analysed as a measure of S-CK-MB) increased from 3.0±0.6 U l–1 (0.05 ±0.01 ukat l–1) to a maximum of 10.2 ±1.8 U l–1 (0.17 ± 0.03 ukat l–1), with seven patients reaching a S-CK-B value above the discrimination limit for myocardial infarction. The relationship between S-CK and S-CK-B values, however, indicated a skeletal muscle origin of the enzyme release. The maximal activity of both S-CK (r = 0.79; P<0.001) and S-CK-B (r = 0.70; P<0.001) correlated positively to the cumulative delivered energy.
Thus, the release of S-CK and S-CK-B after elective cardioversion is correlated to the cumulative energy delivered, indicating increased skeletal muscle damage with greater energy. If the S-CK activity curve is interpreted without access to the S-CK-B activity this might interfere with the diagnosis of myocardial infarction.
Key Words: Creatine kinase • isoenzymes • DC-conversion
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Goktekin, M. Melek, B. Gorenek, A. Birdane, G. Kudaiberdieva, Y. Cavusoglu, and B. Timuralp Cardiac Troponin T and Cardiac Enzymes After External Transthoracic Cardioversion of Ventricular Arrhythmias in Patients With Coronary Artery Disease Chest, December 1, 2002; 122(6): 2050 - 2054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schluter, H. Baum, A. Plewan, and D. Neumeier Effects of Implantable Cardioverter Defibrillator Implantation and Shock Application on Biochemical Markers of Myocardial Damage Clin. Chem., March 1, 2001; 47(3): 459 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Boriani, M. Biffi, V. Cervi, G. Bronzetti, G. Magagnoli, R. Zannoli, and A. Branzi Evaluation of Myocardial Injury Following Repeated Internal Atrial Shocks by Monitoring Serum Cardiac Troponin I Levels Chest, August 1, 2000; 118(2): 342 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.A. Morrow and E.M. Antman Cardiac marker elevation after cardioversion: sorting out chicken and egg Eur. Heart J., February 1, 2000; 21(3): 171 - 173. [PDF]
|
|
|
|
|
|
M Lund, J.K French, R.N Johnson, B.F Williams, and H.D White Serum troponins T and I after elective cardioversion Eur. Heart J., February 1, 2000; 21(3): 245 - 253. [Abstract] [PDF]
|
|
|
|
 |
|
 T. M. Hurst, M. Hinrichs, C. Breidenbach, N. Katz, and B. Waldecker Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators J. Am. Coll. Cardiol., August 1, 1999; 34(2): 402 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Greaves and T Crake Cardiac troponin T does not increase after electrical cardioversion for atrial fibrillation or atrial flutter Heart, September 1, 1998; 80(3): 226 - 228. [Abstract] [Full Text]
|
|
|
|
|
|
A C R Rao, N Naeem, C John, P O Collinson, R Canepa-Anson, and S P Joseph Direct current cardioversion does not cause cardiac damage: evidence from cardiac troponin T estimation Heart, September 1, 1998; 80(3): 229 - 230. [Abstract] [Full Text]
|
|